196 related articles for article (PubMed ID: 9143054)
21. Brachytherapy of intra ocular tumors using 'BARC I-125 Ocu-Prosta seeds': an Indian experience.
Khetan V; Gopal L; Shanmugam MP; Gupta A; Sharma T; Bhende P; Muthukumar S; Subramaniam R; Kuppuswamy T; Saxena SK; Dash A
Indian J Ophthalmol; 2014 Feb; 62(2):158-62. PubMed ID: 24618486
[TBL] [Abstract][Full Text] [Related]
22. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
23. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
Gagne NL; Rivard MJ
Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
[TBL] [Abstract][Full Text] [Related]
24. The Collaborative Ocular Melanoma Study: an overview.
Margo CE
Cancer Control; 2004; 11(5):304-9. PubMed ID: 15377989
[TBL] [Abstract][Full Text] [Related]
25. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
26. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
27. The treatment of primary intraocular malignancy.
Brady LW; Markoe AM; Amendola BE; Karlsson UL; Micaily B; Shields JA; Augsburger JJ
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1355-61. PubMed ID: 3058658
[TBL] [Abstract][Full Text] [Related]
28. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
29. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications.
Reichstein D; Karan K
Curr Opin Ophthalmol; 2018 May; 29(3):191-198. PubMed ID: 29538180
[TBL] [Abstract][Full Text] [Related]
30. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment.
Shields CL; Shields JA; De Potter P; Minelli S; Hernandez C; Brady LW; Cater JR
Ophthalmology; 1993 Feb; 100(2):216-24. PubMed ID: 8437830
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy for choroidal melanoma.
Finger PT
Surv Ophthalmol; 1997; 42(3):215-32. PubMed ID: 9406368
[TBL] [Abstract][Full Text] [Related]
32. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
Shields CL; Naseripour M; Shields JA; Freire J; Cater J
Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
[TBL] [Abstract][Full Text] [Related]
33. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
;
Brachytherapy; 2014; 13(1):1-14. PubMed ID: 24373763
[TBL] [Abstract][Full Text] [Related]
34. (125)I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain.
Correa R; Pera J; Gómez J; Polo A; Gutiérrez C; Caminal JM; Modolell I; Navarro V; Guedea F
Brachytherapy; 2009; 8(3):290-6. PubMed ID: 19428308
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation of the eye with plaque brachytherapy: a single institution experience report of eight consecutive patients submitted to retreatment after local relapse of malignant disease of the eye.
Gaspar de Souza Neves DF; Ferragut MA; Ferreira DV; Marconi DG; Assis Pellizzon AC; Conte Maia MA; Fernandes Costela Freitas MA; Motono Chojniak MM; Guedes de Castro D
Brachytherapy; 2014; 13(3):281-4. PubMed ID: 24231148
[TBL] [Abstract][Full Text] [Related]
36. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
37. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric and radiobiologic comparison of
Gorovets D; Gagne NL; Melhus CS
Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
[TBL] [Abstract][Full Text] [Related]
40. Cobalt60 plaques in recurrent retinoblastoma.
Fass D; McCormick B; Abramson D; Ellsworth R
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):625-7. PubMed ID: 1869458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
